RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has released its financial results for the third quarter ended ...

Fidaxomicin use in the treatment of CDI has significantly increased since the IDSA 2021 Clinical Guideline Update; however, its use is still low.

EXCLUSIVE: The daughter of a terminally ill woman who travelled to Dignitas says the vote in Parliament will be "a monumental ...

Throughout 2024, the FDA issued new drug approvals and expanded treatment indications across various rheumatologic diseases.